Cero Therapeutics Holdings CERO Growth Metrics (2022-2026)

OTC CERO
$0.00 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Cero Therapeutics Holdings Quarterly Growth Metrics

Periods 18 quarters
Latest Jun 2026

Cero Therapeutics Holdings reported asset growth of -69.37% for the quarter ended Jun 2026. These growth metrics cover 18 quarters of results from Mar 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y) -76.47%-91.97%-92.15%-95.31%-87.90%-37.27%-47.76%-23.36%21.08%-11.72%-15.85%-39.75%-41.34%-72.41%-69.37%
Assets Growth (3y) -67.46%-64.58%-67.44%-72.12%-55.87%-46.54%-48.74%
Assets (QoQ) -0.17%-0.03%0.40%-76.52%-65.94%-2.22%-39.97%-39.48%76.59%-18.58%-11.92%-4.39%28.75%-22.39%-36.94%-6.91%-39.44%-13.84%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) -56.68%-81.00%236.49%2,479.05%3,365.63%2,740.17%107.78%13.29%-9.44%-40.18%-50.03%-83.52%-71.61%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) 44.68%81.35%51.73%68.86%107.30%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) -62.58%-40.91%13.09%1,245.43%186.84%-20.60%-7.32%-1.57%56.40%-36.53%-38.77%-17.79%-48.42%9.33%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) -107.65%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) -100.06%385.24%1,894.41%-342.91%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) 35.81%-273.08%-46.90%49.98%-2,146.30%-300.55%-977.06%-725.31%-0.07%-30.70%-16.19%-148.44%162.98%-70.88%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y) -143.46%-169.30%-163.92%-117.26%152.81%-107.59%
Cash from Operations (QoQ)Cash from Ops. (QoQ) 23.17%26.34%-114.00%46.99%-346.51%71.00%27.14%-2,280.73%20.38%22.01%44.17%-188.66%-3.99%30.67%-19.38%173.18%-382.14%
Dividends payables Growth (1y) 0.00%
Dividends payables (QoQ) 0.00%0.00%
EBITDA Margin Growth (1y) 2.47M
EBITDA Margin (QoQ) 9.30M-56.93M53.97M-3.86M
EBIT Growth (1y) -540.97%-83.53%12.91%-49.89%-113.29%-186.68%-86.90%-35.45%8.24%0.90%-111.23%2.12%18.57%
EBIT Growth (3y) -132.35%-73.40%-50.93%-25.72%-16.80%
EBIT Margin Growth (1y) 2.61M
EBIT Margin (QoQ) 9.54M-57.81M54.81M-3.92M
EBIT (QoQ) -122.18%-53.87%-89.40%1.01%36.38%26.99%-225.99%-40.86%14.49%52.40%-136.25%4.58%7.65%-1.46%-9.48%20.62%
EBT Growth (1y) -1,148.62%-312.65%-193.60%-59.93%-270.78%-1,326.58%-692.20%-32.84%8.81%0.80%-116.27%-1.20%3.71%
EBT Growth (3y) -248.20%-217.79%-162.25%-29.07%-48.21%
EBT Margin Growth (1y) 2.60M
EBT Margin (QoQ) 9.54M-57.81M54.81M-3.93M
EBT (QoQ) 229.93%90.41%-944.05%40.21%77.87%16.20%-1,342.26%-38.62%14.86%53.46%-141.84%4.84%7.38%-1.46%-13.16%9.45%
EPS (Basic) Growth (1y) -2,089.87%-6,267.04%-5,894.83%-1,559.40%66.02%51.10%33.86%-1,781.70%-1,199.95%-1,941.09%-222.73%84.29%99.36%98.87%
EPS (Basic) Growth (3y) -359.06%-759.76%-400.92%-266.03%69.49%51.66%
EPS (Basic) (QoQ) 70.48%175.74%-417.59%-2,984.29%14.18%31.06%9.05%36.83%-23.49%6.77%-2,487.46%56.36%-93.90%85.26%-25.91%98.21%-241.20%
EPS (Diluted) Growth (1y) -337.97%-851.12%-909.26%-144.11%47.12%34.53%42.80%-2,513.86%-735.36%-1,941.09%-434.40%84.29%99.36%98.87%
EPS (Diluted) Growth (3y) -168.46%-402.79%-199.03%-115.59%69.49%46.72%
EPS (Diluted) (QoQ) 70.48%175.74%-410.84%-530.26%35.90%35.55%6.24%-36.54%20.64%43.70%-4,184.43%56.36%-93.90%85.26%-25.91%98.21%-241.20%
FCF Margin Growth (1y) 0.84M
FCF Margin (QoQ) 5.93M-51.99M48.95M-2.04M
Free Cash Flow Growth (1y)FCF Growth (1y) 35.81%-273.08%-46.90%49.98%-2,146.30%-300.55%-977.06%-725.31%-0.07%-30.70%-16.19%-148.44%162.98%-70.88%
Free Cash Flow Growth (3y)FCF Growth (3y) -143.46%-169.30%-163.92%-117.26%152.81%-107.59%
Free Cash Flow (QoQ)FCF (QoQ) 23.17%26.34%-114.00%46.99%-346.51%71.00%27.14%-2,280.73%20.38%22.01%44.17%-188.66%-3.99%30.67%-19.38%173.18%-382.14%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) 99.97%-646.48%89.81%23.12%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y) 94.24%48.42%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) 99.97%-23,976.28%99.43%7.94%-490.20%-228.59%95.69%80.87%
Net Cash Flow Growth (1y)NCF Growth (1y) 5.02%67.04%107.90%-123.12%1,027.89%-1,112.52%-2,036.30%99.87%-30.89%-100.92%-567.34%-613.99%153.46%-188.93%
Net Cash Flow Growth (3y)NCF Growth (3y) 100.75%-100.25%-116.96%-26.04%163.30%-312.89%
Net Cash Flow (QoQ)NCF (QoQ) 23.17%26.34%103,534.95%-100.16%73.33%117.66%-302,626.23%106.51%-134.84%71.80%80.08%3,630.93%-201.30%6.33%78.69%1,353.46%-215.47%
Net Income Growth (1y) -545.07%-1,775.53%-1,696.77%-381.65%29.15%-17.02%-213.33%153.11%-195.57%-121.24%-14.86%-775.80%-15.28%81.01%
Net Income Growth (3y) -138.16%-264.82%-290.33%-158.56%-34.14%21.07%
Net Income (QoQ) 70.48%175.74%-410.84%-828.27%14.18%35.52%6.24%-36.54%-41.75%-72.66%115.89%-859.93%-6.10%10.35%6.50%-29.63%82.52%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -545.07%-1,775.53%-1,696.77%-381.65%29.15%-17.02%-213.33%-67.01%-215.73%-1,129.97%-172.15%-2,192.94%-7.92%2.20%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y) -143.45%-546.29%-416.96%-469.23%-34.14%-141.45%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) 70.48%175.74%-410.84%-828.27%14.18%35.52%6.24%-36.54%-41.75%-72.66%50.02%-158.13%-452.20%61.80%-321.06%87.85%-400.44%
Net Margin Growth (1y) -9.81M
Net Margin (QoQ) 9.14M-63.73M42.30M2.48M
Operating Income Growth (1y)Op. Inc Growth (1y) -540.97%-83.53%12.91%-49.89%-113.29%-186.68%-86.90%-35.45%8.24%0.90%-111.23%2.12%18.57%
Operating Income Growth (3y)Op. Inc Growth (3y) -132.35%-73.40%-50.93%-25.72%-16.80%
Operating Income (QoQ)Op. Inc (QoQ) -122.18%-53.87%-89.40%1.01%36.38%26.99%-225.99%-40.86%14.49%52.40%-136.25%4.58%7.65%-1.46%-9.48%20.62%
Operating Margin Growth (1y) 2.61M
Operating Margin (QoQ) 9.54M-57.81M54.81M-3.92M
Profit After Tax Growth (1y)PAT Growth (1y) -1,188.65%-495.28%-7.65%-59.93%-259.26%-1,216.60%-623.81%-32.84%8.81%0.80%-116.27%-1.20%3.71%
Profit After Tax Growth (3y)PAT Growth (3y) -248.20%-277.10%-156.37%-29.07%-46.66%
Profit After Tax (QoQ)PAT (QoQ) 175.74%-410.84%-786.94%38.29%76.77%15.35%-1,217.75%-38.62%14.86%53.46%-141.84%4.84%7.38%-1.46%-13.16%9.45%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) -45.33%-46.99%-48.18%-49.84%-53.43%-59.21%-67.10%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) -11.76%-13.40%-15.41%-15.42%-14.44%-15.35%-18.12%-21.47%-25.07%-31.72%
Return on Assets [ROA] Growth (1y)ROA Growth (1y) -0.01M-0.01M-0.02M-0.02M-0.02M-0.01M-0.01M-0.02M-0.04M-0.07M
Return on Assets [ROA] Growth (3y)ROA Growth (3y) -0.06M-0.09M
Return on Assets [ROA] (QoQ)ROA (QoQ) 0.00M0.00M0.00M0.00M0.00M-0.01M0.00M827.00634.00-0.01M-0.02M-0.01M-0.03M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) -0.01M0.00M-0.01M
Return on Equity [ROE] (QoQ)ROE (QoQ) -2.000.00M0.00M
Return on Sales [ROS] Growth (1y)ROS Growth (1y) 2.61M-15.47M
Return on Sales [ROS] (QoQ)ROS (QoQ) 9.54M-57.81M54.81M-3.92M-8.55M
Revenue Growth (1y) 105.89%181.15%34.36%-118.32%
Revenue (QoQ) -17.62%126.02%1,005.45%-98.26%1,520.71%-56.91%-250.74%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 219.78%-97.86%1,900.00%-5,871.21%238.83%2,257.67%-12.97%126.63%430.41%58.64%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y) 285.91%-7.11%
Share-based Compensation (QoQ)Stock Comp. (QoQ) 4,874.42%-98.57%-15.52%432.67%-66.67%1,233.33%-343.78%131.27%131.94%-50.78%-25.41%522.90%-30.63%
Tax Rate (QoQ) 0.02M
Total Debt Growth (1y) -7.74%-38.07%-78.45%-92.67%
Total Debt Growth (3y) -14.03%
Total Debt (QoQ) 0.00%80.77%18.72%-57.01%-32.88%-37.10%-59.60%

Cero Therapeutics Holdings Growth Metrics API

Pull Cero Therapeutics Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CERO&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY